Compare KARD & MCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | KARD | MCB |
|---|---|---|
| Founded | 2023 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2026 | 2017 |
| Metric | KARD | MCB |
|---|---|---|
| Price | $11.56 | $90.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $41.00 | ★ $108.33 |
| AVG Volume (30 Days) | ★ 441.3K | 132.1K |
| Earning Date | 11-12-2026 | 10-20-2026 |
| Dividend Yield | N/A | ★ 1.73% |
| EPS Growth | N/A | ★ 11.64 |
| EPS | N/A | ★ 6.91 |
| Revenue | N/A | ★ $11,053,000.00 |
| Revenue This Year | N/A | $21.78 |
| Revenue Next Year | N/A | $11.60 |
| P/E Ratio | ★ N/A | $13.38 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.23 | $71.71 |
| 52 Week High | $27.00 | $102.04 |
| Indicator | KARD | MCB |
|---|---|---|
| Relative Strength Index (RSI) | 35.74 | 40.18 |
| Support Level | N/A | $90.55 |
| Resistance Level | $16.26 | $94.30 |
| Average True Range (ATR) | 1.30 | 2.62 |
| MACD | -0.24 | -0.77 |
| Stochastic Oscillator | 0.60 | 5.52 |
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.